Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 26 16
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 31 11
Regdanvimab Authorized Experimental Antiviral Jan/18/2023 6 4
Sotrovimab Emergency use authorization Experimental Antiviral Jul/14/2022 7 2
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 5 16
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 11 15
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022 11 0
Cilgavimab Emergency use authorization Experimental Antiviral Jun/18/2022 9 3
Tixagevimab Emergency use authorization Experimental Antiviral Jun/18/2022 9 3
COV2-2196 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2022 4 4